The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device ...
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD will pay a $175 million civil penalty to settle charges ...
CareFusion Corporation has initiated a class 1 recall of the Alaris PC unit model 8015 with software version 9.12 because of a voltage problem, according to the US Food and Drug Administration (FDA).
The U.S. FDA said that BD (NYSE:BDX) has expanded its Class I voluntary recall to inform customers about the worst-case performance of the BD Alaris Pump Module model 8100 when used with certain ...
After facing down more than a dozen serious recalls in the last decade, BD’s Alaris infusion pump is involved in yet another wide-ranging Class I recall, this time for a bezel piece installed by ...
BD CEO Tom Polen noted that the newly FDA-cleared Alaris infusion pump system “addresses all open recalls,” spanning recent hardware, software and cybersecurity issues. (BD) Since the start of 2020, ...
Becton, Dickinson and Company’s (BDX Quick Quote BDX - Free Report) , or popularly known as BD, initiated the recall of its infusion pumps last month after customer reports indicated software issues, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results